Trial Profile
Clinical Trials Insight: 700043873
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2009
Price :
$35
*
At a glance
- Drugs Acetylcysteine/bethanechol chloride (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors DiaMedica Therapeutics
- 28 Apr 2009 New trial record.